Abstract
Background: Verbal speech-in-noise (SIN) measures are impaired in early Alzheimer's disease (AD) but may be confounded by linguistic and cultural factors. We investigated whether non-verbal auditory memory could predict cognitive impairment in AD. Methods: We evaluated 158 cognitively healthy individuals, 26 with mild cognitive impairment (MCI), and 28 with AD dementia using the Addenbrooke's Cognitive Examination (ACE-III), pure-tone audiometry, verbal SIN tests, and non-verbal auditory memory tests for basic sound features. Group differences were assessed adjusting for age, sex, and education. Logistic regression and receiver operating characteristic (ROC) analyses compared model fit of verbal and non-verbal auditory variables. Results: All auditory cognition measures were significantly associated with cognition. Non-verbal measures provided a better fit to diagnosis than verbal measures (AIC difference >10), although ROC analyses showed no significant differences between models. Conclusions: Non-verbal auditory measures are effective measures in distinguishing between cognitively healthy, MCI, and AD dementia individuals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors have no conflicts of interests or competing interests to declare. Data is available upon request to the corresponding author. ML has received funding from the Guarantors of Brain (Brain Entry Fellowship) and Medical Research Council (MR/V006568/1) in the United Kingdom. CJP receives funding from the National Institute for Health and Care Research Manchester Biomedical Research Centre (NIHR203308). JT receives funding and support from the National Institute for Health Research Biomedical Research Centre (NIHR203309), United Kingdom in Newcastle upon Tyne. TG receives funding from the Medical Research Council (MR/T032553/1), Wellcome Trust (WT106964MA) and National Institute on Deafness and Other Communication Disorders (DC000242 36).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Oxford C NHS Research Ethics Committee (21/SC/0139)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Converted to a research article from a short report
Data Availability
All data produced in the present study are available upon reasonable request to the authors
